
Current Price | $174.22 | Mkt Cap | $9.5B |
---|---|---|---|
Open | $172.48 | P/E Ratio | 58.11 |
Prev. Close | $171.02 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $170.93 - $174.22 | Volume | 36,379 |
52-Wk Range | $137.65 - $262.26 | Avg. Daily Vol. | 542,888 |
A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.
Current Price | $174.22 | Mkt Cap | $9.5B |
---|---|---|---|
Open | $172.48 | P/E Ratio | 58.11 |
Prev. Close | $171.02 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $170.93 - $174.22 | Volume | 36,379 |
52-Wk Range | $137.65 - $262.26 | Avg. Daily Vol. | 542,888 |
The best Bull and Bear pitches based on recency and number of recommendations.
https://www.fool.com/investing/2022/01/20/2-healthcare-stocks-that-could-help-set-you-up-for/
These medical corporations tend to have spurts of large growth with long periods of notable decline. Just as Genetic Technologies as been fluctuating over the past year (a range from ~$2.50 - ~$10.00), this company follows a very similar trend. It… More
Read the most recent pitches from players about RGEN.
Recs
https://www.fool.com/investing/2022/01/20/2-healthcare-stocks-that-could-help-set-you-up-for/
Recs
10000000146
Recs
RGEN is often taken as a normal biotech. It ain't. It's product is in most cases the raw material, reagent, or quality control for the process used by a biotech company to produce product. And in most cases must be resupplied over time. In effect it produces the "blades" for the razors the biotechs produce. The notion changes risk/reward calculus. Evidence history of performance.
Find the members with the highest scoring picks in RGEN.
Stevegoldenfool (< 20) Score: +5,022.91
The Score Leader is the player with the highest score across all their picks in RGEN.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
Stevegoldenfool | < 20 | 9/26/2011 |
![]() |
5Y | $3.22 | +5,291.15% | +268.24% | +5,022.91 | 0 Comment | |
TXawlman | 95.32 | 10/26/2006 |
![]() |
5Y | $3.37 | +5,052.72% | +223.55% | +4,829.17 | 1 Comment | |
toroandbruin | 77.91 | 10/25/2006 |
![]() |
1Y | $3.37 | +5,051.19% | +223.93% | +4,827.25 | 0 Comment | |
sincroton | < 20 | 8/25/2006 |
![]() |
1Y | $3.36 | +5,066.52% | +247.22% | +4,819.29 | 1 Comment | |
warbucks52 | < 20 | 8/25/2006 |
![]() |
1Y | $3.36 | +5,066.52% | +247.39% | +4,819.13 | 0 Comment | |
runic42 | < 20 | 10/2/2006 |
![]() |
1Y | $3.40 | +5,005.74% | +235.51% | +4,770.22 | 0 Comment | |
Vanter1 | 99.39 | 11/11/2011 |
![]() |
5Y | $3.41 | +4,990.76% | +232.97% | +4,757.80 | 0 Comment | |
marky985 | < 20 | 10/27/2008 |
![]() |
3Y | $3.32 | +5,128.77% | +400.60% | +4,728.17 | 0 Comment | |
youmustwhipit | 78.51 | 10/27/2008 |
![]() |
NS | $3.32 | +5,128.77% | +400.60% | +4,728.17 | 0 Comment | |
wonderpiks | 95.35 | 5/6/2010 |
![]() |
5Y | $3.42 | +4,975.88% | +263.01% | +4,712.87 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.